BACKGROUND: Maternal smoking during pregnancy (MSDP) is an independent risk factor for offspring nicotine dependence (ND), but mechanisms remain unknown. We investigated prenatal glucocorticoid (cortisol) and androgen (testosterone) associations with offspring ND over 40 years and the possibility that prenatal glucocorticoids and androgens would mediate links between MSDP and offspring ND. METHODS: Participants were 1086 mother-adult offspring pairs (59% female) from the New England Family Study, a 40-year longitudinal follow-up of the Collaborative Perinatal Project. MSDP was assessed prospectively at each prenatal visit. Maternal cortisol, testosterone, and cotinine (nicotine metabolite) were assayed from third trimester maternal sera. Offspring lifetime ND was assessed via structured interview. RESULTS: Significant bivariate associations emerged for: 1) MSDP/cotinine and lifetime ND; and 2) maternal cortisol and lifetime ND, for daughters only. In multivariate models, maternal cortisol and MSDP/cotinine remained significantly and independently associated with increased odds of lifetime ND of daughters. However, cortisol did not mediate the MSDP-lifetime ND relation. No associations emerged between maternal testosterone and offspring ND. CONCLUSIONS: Results provide the first evidence in support of prenatal glucocorticoid programming of adult ND over 40 years in daughters only. Our study highlights two independent prenatal pathways leading to increased risk for ND in daughters: elevated prenatal glucocorticoids and MSDP/nicotine exposure. Daughter-specific effects of glucocorticoid and MSDP programming over 40 years highlight the breadth and persistence of sexually dimorphic programming effects in humans. Results do not support androgen programming of offspring ND.
BACKGROUND: Maternal smoking during pregnancy (MSDP) is an independent risk factor for offspring nicotine dependence (ND), but mechanisms remain unknown. We investigated prenatal glucocorticoid (cortisol) and androgen (testosterone) associations with offspring ND over 40 years and the possibility that prenatal glucocorticoids and androgens would mediate links between MSDP and offspring ND. METHODS:Participants were 1086 mother-adult offspring pairs (59% female) from the New England Family Study, a 40-year longitudinal follow-up of the Collaborative Perinatal Project. MSDP was assessed prospectively at each prenatal visit. Maternal cortisol, testosterone, and cotinine (nicotine metabolite) were assayed from third trimester maternal sera. Offspring lifetime ND was assessed via structured interview. RESULTS: Significant bivariate associations emerged for: 1) MSDP/cotinine and lifetime ND; and 2) maternal cortisol and lifetime ND, for daughters only. In multivariate models, maternal cortisol and MSDP/cotinine remained significantly and independently associated with increased odds of lifetime ND of daughters. However, cortisol did not mediate the MSDP-lifetime ND relation. No associations emerged between maternal testosterone and offspring ND. CONCLUSIONS: Results provide the first evidence in support of prenatal glucocorticoid programming of adult ND over 40 years in daughters only. Our study highlights two independent prenatal pathways leading to increased risk for ND in daughters: elevated prenatal glucocorticoids and MSDP/nicotine exposure. Daughter-specific effects of glucocorticoid and MSDP programming over 40 years highlight the breadth and persistence of sexually dimorphic programming effects in humans. Results do not support androgen programming of offspring ND.
Authors: Stephen E Gilman; Laurie T Martin; David B Abrams; Ichiro Kawachi; Laura Kubzansky; Eric B Loucks; Richard Rende; Rima Rudd; Stephen L Buka Journal: Int J Epidemiol Date: 2008-01-06 Impact factor: 7.196
Authors: William R Lovallo; Thomas L Whitsett; Mustafa al'Absi; Bong Hee Sung; Andrea S Vincent; Michael F Wilson Journal: Psychosom Med Date: 2005 Sep-Oct Impact factor: 4.312
Authors: Laura R Stroud; George D Papandonatos; Meaghan McCallum; Tessa Kehoe; Amy L Salisbury; Marilyn A Huestis Journal: Neurotoxicol Teratol Date: 2018-09-26 Impact factor: 3.763
Authors: Laura R Stroud; George D Papandonatos; Stephanie H Parade; Amy L Salisbury; Maureen G Phipps; Barry M Lester; James F Padbury; Carmen J Marsit Journal: Psychosom Med Date: 2016 Nov/Dec Impact factor: 4.312
Authors: Laura R Stroud; George D Papandonatos; Nancy C Jao; Raymond Niaura; Stephen Buka; Neal L Benowitz Journal: Drug Alcohol Depend Date: 2022-02-17 Impact factor: 4.492
Authors: Laura R Stroud; George D Papandonatos; Nancy C Jao; Chrystal Vergara-Lopez; Marilyn A Huestis; Amy L Salisbury Journal: Neurotoxicol Teratol Date: 2020-04-11 Impact factor: 3.763
Authors: Lynda J Stinson; Laura R Stroud; Stephen L Buka; Charles B Eaton; Bing Lu; Raymond Niaura; Eric B Loucks Journal: Psychosom Med Date: 2015-04 Impact factor: 4.312
Authors: Laura R Stroud; George D Papandonatos; Amy L Salisbury; Maureen G Phipps; Marilyn A Huestis; Raymond Niaura; James F Padbury; Carmen J Marsit; Barry M Lester Journal: Child Dev Date: 2016 Jan-Feb